<DOC>
	<DOCNO>NCT00858208</DOCNO>
	<brief_summary>Efficacy safety MACUGEN patient suffer neovascular age-related macular degeneration routine clinical practice least good demonstrate randomized multicenter clinical trial .</brief_summary>
	<brief_title>Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice .</brief_title>
	<detailed_description>Eligible patient routine clinical practice</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>adult neovascular agerelated macula degeneration accord SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>efficacy safety Macugen routine clinical practice</keyword>
</DOC>